423 related articles for article (PubMed ID: 25934888)
21. Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth.
O'Neill CF; Urs S; Cinelli C; Lincoln A; Nadeau RJ; León R; Toher J; Mouta-Bellum C; Friesel RE; Liaw L
Am J Pathol; 2007 Sep; 171(3):1023-36. PubMed ID: 17675579
[TBL] [Abstract][Full Text] [Related]
22. Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations.
Fischer M; Yen WC; Kapoun AM; Wang M; O'Young G; Lewicki J; Gurney A; Hoey T
Cancer Res; 2011 Mar; 71(5):1520-5. PubMed ID: 21193546
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias.
Lee SH; Jeong EG; Yoo NJ; Lee SH
APMIS; 2007 Dec; 115(12):1357-63. PubMed ID: 18184405
[TBL] [Abstract][Full Text] [Related]
24. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
[TBL] [Abstract][Full Text] [Related]
25. IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer.
Wang D; Xu J; Liu B; He X; Zhou L; Hu X; Qiao F; Zhang A; Xu X; Zhang H; Wicha MS; Zhang L; Shao ZM; Liu S
Cell Death Differ; 2018 Feb; 25(2):330-339. PubMed ID: 29027990
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B virus X protein and hypoxia‑inducible factor-1α stimulate Notch gene expression in liver cancer cells.
Yang SL; Ren QG; Zhang T; Pan X; Wen L; Hu JL; Yu C; He QJ
Oncol Rep; 2017 Jan; 37(1):348-356. PubMed ID: 27840976
[TBL] [Abstract][Full Text] [Related]
27. Notch signaling dynamics in the adult healthy prostate and in prostatic tumor development.
Pedrosa AR; Graça JL; Carvalho S; Peleteiro MC; Duarte A; Trindade A
Prostate; 2016 Jan; 76(1):80-96. PubMed ID: 26419726
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast Cancer.
Strati TM; Kotoula V; Kostopoulos I; Manousou K; Papadimitriou C; Lazaridis G; Lakis S; Pentheroudakis G; Pectasides D; Pazarli E; Christodoulou C; Razis E; Pavlakis K; Magkou C; Chrisafi S; Aravantinos G; Bafaloukos D; Papakostas P; Gogas H; Kalogeras KT; Fountzilas G
Anticancer Res; 2017 May; 37(5):2323-2334. PubMed ID: 28476798
[TBL] [Abstract][Full Text] [Related]
30. Notch1 and Notch2 receptors regulate mouse and human gastric antral epithelial cell homoeostasis.
Gifford GB; Demitrack ES; Keeley TM; Tam A; La Cunza N; Dedhia PH; Spence JR; Simeone DM; Saotome I; Louvi A; Siebel CW; Samuelson LC
Gut; 2017 Jun; 66(6):1001-1011. PubMed ID: 26933171
[TBL] [Abstract][Full Text] [Related]
31. Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy.
McAuliffe SM; Morgan SL; Wyant GA; Tran LT; Muto KW; Chen YS; Chin KT; Partridge JC; Poole BB; Cheng KH; Daggett J; Cullen K; Kantoff E; Hasselbatt K; Berkowitz J; Muto MG; Berkowitz RS; Aster JC; Matulonis UA; Dinulescu DM
Proc Natl Acad Sci U S A; 2012 Oct; 109(43):E2939-48. PubMed ID: 23019585
[TBL] [Abstract][Full Text] [Related]
32. Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies.
Bernasconi-Elias P; Hu T; Jenkins D; Firestone B; Gans S; Kurth E; Capodieci P; Deplazes-Lauber J; Petropoulos K; Thiel P; Ponsel D; Hee Choi S; LeMotte P; London A; Goetcshkes M; Nolin E; Jones MD; Slocum K; Kluk MJ; Weinstock DM; Christodoulou A; Weinberg O; Jaehrling J; Ettenberg SA; Buckler A; Blacklow SC; Aster JC; Fryer CJ
Oncogene; 2016 Nov; 35(47):6077-6086. PubMed ID: 27157619
[TBL] [Abstract][Full Text] [Related]
33. Targeted Notch1 inhibition with a Notch1 antibody, OMP-A2G1, decreases tumor growth in two murine models of prostate cancer in association with differing patterns of DNA damage response gene expression.
Ahmed AA; Robinson T; Palande M; Escara-Wilke J; Dai J; Keller ET
J Cell Biochem; 2019 Oct; 120(10):16946-16955. PubMed ID: 31099068
[TBL] [Abstract][Full Text] [Related]
34. NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells.
Geles KG; Gao Y; Giannakou A; Sridharan L; Yamin TT; Zhang J; Karim R; Bard J; Piche-Nicholas N; Charati M; Maderna A; Lucas J; Golas J; Guffroy M; Pirie-Shepherd S; Roy M; Qian J; Franks T; Zhong W; O'Donnell CJ; Tchistiakova L; Gerber HP; Sapra P
Cell Rep Med; 2021 May; 2(5):100279. PubMed ID: 34095881
[TBL] [Abstract][Full Text] [Related]
35. Pathobiology of Notch2 in lung cancer.
Motooka Y; Fujino K; Sato Y; Kudoh S; Suzuki M; Ito T
Pathology; 2017 Aug; 49(5):486-493. PubMed ID: 28666642
[TBL] [Abstract][Full Text] [Related]
36. Molecular pathways: context-dependent approaches to Notch targeting as cancer therapy.
Egloff AM; Grandis JR
Clin Cancer Res; 2012 Oct; 18(19):5188-95. PubMed ID: 22773520
[TBL] [Abstract][Full Text] [Related]
37. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma.
Giovannini C; Minguzzi M; Baglioni M; Fornari F; Giannone F; Ravaioli M; Cescon M; Chieco P; Bolondi L; Gramantieri L
Oncotarget; 2014 Nov; 5(21):10607-20. PubMed ID: 25431954
[TBL] [Abstract][Full Text] [Related]
38. Notch3 pathway alterations in ovarian cancer.
Hu W; Liu T; Ivan C; Sun Y; Huang J; Mangala LS; Miyake T; Dalton HJ; Pradeep S; Rupaimoole R; Previs RA; Han HD; Bottsford-Miller J; Zand B; Kang Y; Pecot CV; Nick AM; Wu SY; Lee JS; Sehgal V; Ram P; Liu J; Tucker SL; Lopez-Berestein G; Baggerly KA; Coleman RL; Sood AK
Cancer Res; 2014 Jun; 74(12):3282-93. PubMed ID: 24743243
[TBL] [Abstract][Full Text] [Related]
39. Gliotoxin is a potent NOTCH2 transactivation inhibitor and efficiently induces apoptosis in chronic lymphocytic leukaemia (CLL) cells.
Hubmann R; Hilgarth M; Schnabl S; Ponath E; Reiter M; Demirtas D; Sieghart W; Valent P; Zielinski C; Jäger U; Shehata M
Br J Haematol; 2013 Mar; 160(5):618-29. PubMed ID: 23278106
[TBL] [Abstract][Full Text] [Related]
40. Notch3 activation promotes invasive glioma formation in a tissue site-specific manner.
Pierfelice TJ; Schreck KC; Dang L; Asnaghi L; Gaiano N; Eberhart CG
Cancer Res; 2011 Feb; 71(3):1115-25. PubMed ID: 21245095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
